The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: Association with high-molecular weight adiponectin and hepatic enzymes

Translational Research

Volumn 162, Issue 5, 2013, Pages 309-316

  Aso, Yoshimasa ^a   Terasawa, Tomoko ^a   Kato, Kanako ^a   Jojima, Teruo ^a   Suzuki, Kunihiro ^a   Iijima, Toshie ^a   Kawagoe, Yoshiaki ^a   Mikami, Shigeru ^b   Kubota, Yoshiro ^b   Inukai, Toshihiko ^a   Kasai, Kikuo ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b Kikkoman General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; DIPEPTIDYL PEPTIDASE IV; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 84886048045     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2013.07.011     Document Type: Article

References (31)

1. E. Matteucci, and O. Giampietro Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme Curr Med Chem 16 2009 2943 2951
2. R. Yazbeck, G.S. Howarth, and C.A. Abbott Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease? Trends Pharmacol Sci 30 2009 600 607
3. W. Kim, and J.M. Egan The role of incretins in glucose homeostasis and diabetes treatment Pharmacol Rev 60 2008 470 512
4. J.J. Holst The physiology of glucagon-like peptide 1 Physiol Rev 87 2007 1409 1439
5. S. Iwaki-Egawa, Y. Watanabe, Y. Kikuya, and Y. Fujimoto Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence J Biochem 124 1998 428 433
6. C. Durinx, A.M. Lambeir, and E. Bosmans Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides Eur J Biochem 267 2000 5608 5613
7. E. Mannucci, L. Pala, and S. Ciani Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus Diabetologia 48 2005 1168 1172
8. lc levels, but is not acutely affected by food intake Eur J Endocrinol 155 2006 485 493
9. H. Kobayashi, O. Hosono, and T. Mimori Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus J Rheumatol 29 2002 1858 1866
10. N. Busso, N. Wagtmann, and C. Herling Circulating CD26 is negatively associated with inflammation in human and experimental arthritis Am J Pathol 166 2005 433 442
11. Y. Aso, N. Ozeki, and T. Terasawa Serum level of soluble CD26/DPP4 predicts the response to sitagliptin, a dipeptidyl peptidase-4 (DPP4) inhibitor, in patients with type 2 diabetes inadequately controlled by metformin and/or sulfonylurea Transl Res 59 2012 25 31
12. Y. Nakano, S. Tajima, and A. Yoshimi A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin J Lipid Res 47 2006 1572 1582
13. Y. Aso, R. Yamamoto, and S. Wakabayashi Comparison of serum high-molecular-weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin Diabetes 55 2006 1954 1960
14. G.S. Meneilly, H.U. Demuth, C.H. McIntosh, and R.A. Pederson Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose Diabet Med 17 2000 346 350
15. L. Pala, S. Ciani, and I. Dicembrini Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditions Diabet Med 27 2010 691 695
16. S.A. Lee, Y.R. Kim, and E.J. Yang CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus J Clin Endocrinol Metab 98 2013 2553 2561
17. T.M. Wallace, and D.R. Matthews The assessment of insulin resistance in man Diabet Med 1 2002 527 534
18. E. Ortega, J. Koska, A.D. Salbe, P.A. Tataranni, and J.C. Bunt Serum gamma-glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children J Clin Endocrinol Metab 91 2006 1419 1422
19. O.J. Cordero, F.J. Salgado, and M. Nogueira On the origin of serum CD26 and its altered concentration in cancer patients Cancer Immunol Immunother 58 2009 1723 1747
20. D. Lamers, S. Famulla, and N. Wronkowitz Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome Diabetes 60 2011 1917 1925
21. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 2003 1796 1808
22. U. Kintscher, M. Hartge, and K. Hess T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance Arterioscler Thromb Vasc Biol 28 2008 1304 1310
23. J. Zhong, X. Rao, and J. Deiuliis A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation Diabetes 62 2013 149 157
24. A.M. Lambeir, C. Durinx, S. Scharpe, and I. De Meester Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV Crit Rev Clin Lab Sci 40 2003 209 294
25. G. Firneisz, T. Varga, and G. Lengyel Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker PLoS One 5 2010 e12226
26. D.J. Chiang, M.T. Pritchard, and L.E. Nagy Obesity, diabetes mellitus, and liver fibrosis Am J Physiol Gastrointest Liver Physiol 300 2011 G697 G702
27. N. Ozeki, K. Hara, and C. Yatsuka Serum high molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus Metabolism 58 2009 1470 1476
28. T. Yamauchi, J. Kamon, and H. Waki The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 2001 941 946
29. T. Ikeda, E. Kumagai, S. Iwata, and A. Yamakawa Soluble CD26/dipeptidyl peptidase IV enhances the transcription of IL-6 and TNF-α in THP-1 cells and monocytes PLoS One 21 2013 e66520
30. T. Hajri, H. Tao, J. Wattacheril, P. Marks-Shulman, and N.N. Abumrad Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-α and interleukin-6 Am J Physiol Endocrinol Metab 300 2011 E350 E360
31. G.J. Hein, C. Baker, J. Hsieh, S. Farr, and K. Adeli GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states Diabetes 62 2013 373 381